GLI Participants Lose Weight Without Medication
Weight Loss Drugs Rarely Used in dutch Lifestyle Intervention Program, Study Finds
Amsterdam, Netherlands – While weight loss medications are increasingly in the spotlight, a new report from the Dutch National Institute for Public Health and the Habitat (RIVM) reveals they are rarely used in conjunction with the country’s popular lifestyle intervention program.
The program, known as the “Gecombineerde Leefstijlinterventie” (GLI), provides two years of guidance on healthy eating, exercise, and behavior change to help participants achieve enduring weight loss.The RIVM’s latest annual report, which tracks the GLI’s progress since 2019, found that only 1% of participants utilize medications specifically designed for weight loss, such as those for obesity. A larger percentage, 12%, use medications with weight-loss side effects, like some diabetes drugs.This limited use of weight-loss medications means there’s currently insufficient data to assess their impact when combined with the GLI program, according to the RIVM.
Quality of Life Sees significant Boost
Despite the limited use of weight-loss drugs, the GLI program has demonstrably improved participants’ quality of life.The report indicates a 13-point increase on a 0-100 scale, with 0 representing the least healthy and 100 the most healthy.
Interestingly, the advancement in quality of life was even more pronounced among participants who lost more than 5% of their body weight, with a 15-point increase compared to an 11-point increase for those who lost less.
The use of weight-loss medications did not appear to influence these quality-of-life improvements, suggesting the program’s benefits extend beyond mere weight loss.
GLI: A nation-Wide Effort
Since its inception in 2019, over 121,000 Dutch residents have participated in the GLI program. The program, which is covered by the national health insurance system, provides two years of support and guidance on healthy living.
The GLI consists of an active treatment phase followed by a maintenance phase,with the specific duration and content varying depending on the program. Participants can choose from seven recognized GLI programs, depending on availability in their region.
The program’s accessibility and focus on sustainable lifestyle changes have made it a cornerstone of the Netherlands’ efforts to combat obesity and promote public health.
dutch Lifestyle intervention Focuses on Long-term Habits, Not Rapid-Fix Drugs
Amsterdam, Netherlands – While weight loss medications are generating buzz worldwide, a new Dutch study reveals a different approach. The Netherlands’ popular “Gecombineerde Leefstijlinterventie” (GLI) programme, a two-year initiative promoting healthy eating, exercise, adn sustainable behavior change, rarely incorporates these drugs.
The RIVM’s annual report analyzing the GLI program since 2019 found only 1% of participants used medications specifically designed for weight loss. while 12% utilized medications with weight-loss side effects, this limited drug use hinders important data collection on the combined impact.
despite the minimal medication usage, the GLI program boasts impressive results. Participants demonstrated a 13-point increase in quality of life on a 0-100 scale. Intriguingly, those achieving over 5% weight loss saw an even greater enhancement, with a 15-point increase, underscoring the program’s holistic impact.
As its launch in 2019,the GLI program has engaged over 121,000 Dutch residents, recognized by the national health insurance system. This widespread program offers personalized support through seven distinct programs, tailoring its offerings to regional needs.
The GLI’s success highlights the Netherlands’ commitment to tackling obesity and prioritizing long-term, sustainable lifestyle changes over quick-fix solutions.